World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
111
Citations
50905
World Ranking
348
National Ranking
204

Michael L. Cleary publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Michael L. Cleary sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 256 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Michael L. Cleary D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael L. Cleary sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 111 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Michael L. Cleary is affiliated with Stanford University in the United States and has an extensive publication record primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research covers a range of subfields including Molecular Biology, Infectious Diseases, Hematology, Biomedical Engineering, and Public Health, Environmental and Occupational Health.

The scientist's work spans several key topics that include CRISPR and Genetic Engineering, Acute Lymphoblastic Leukemia research, SARS-CoV-2 and COVID-19 Research, Chronic Myeloid Leukemia Treatments, Immune Cell Function and Interaction, Biosensors and Analytical Detection, and SARS-CoV-2 detection and testing.

Michael L. Cleary has published papers in various venues, with frequent contributions to Blood Advances, Nature Medicine, Advanced Healthcare Materials, bioRxiv (Cold Spring Harbor Laboratory), and Cancers.

  • Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants, 2022, Nature Medicine
  • Early Introduction and Rise of the Omicron Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant in Highly Vaccinated University Populations, 2022, Clinical Infectious Diseases
  • Matrix Metalloproteinase-9-Responsive Surface Charge-Reversible Nanocarrier to Enhance Endocytosis as Efficient Targeted Delivery System for Cancer Diagnosis and Therapy, 2021, Advanced Healthcare Materials
  • Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia, 2022, Cancer Gene Therapy
  • Early introduction and rise of the Omicron SARS-CoV-2 variant in highly vaccinated university populations, 2022, bioRxiv (Cold Spring Harbor Laboratory)

Frequent co-authors in Michael L. Cleary's research include Jesús Duque-Afonso, Nicole L. Welch, Brittany A. Petros, Michael Springer, and Bronwyn MacInnis.

Best Publications

  • A revised European-American classification of lymphoid neoplasms : a proposal from the international lymphoma study group

    NL Harris;ES Jaffe;H Stein;PM Banks

  • Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation

    Michael L. Cleary;Stephen D. Smith;Jeffrey Sklar

  • Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18

    Michael L. Cleary;Jeffrey Sklar

  • Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias.

    Douglas C. Tkachuk;Sabine Kohler;Michael L. Cleary

  • Rb targets histone H3 methylation and HP1 to promoters

    Soren J. Nielsen;Robert Schneider;Uta-Maria Bauer;Andrew J. Bannister

  • Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors

    Antonio Cozzio;Emmanuelle Passegué;Paul M. Ayton;Holger Karsunky

  • Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas.

    Lawrence M. Weiss;Roger A. Warnke;Jeffrey Sklar;Michael L. Cleary

  • Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia.

    Tim C.P. Somervaille;Michael L. Cleary

  • Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor

    Jamison Nourse;Julia D. Mellentin;Naomi Galili;Joyce Wilkinson

  • Leukemia Proto-Oncoprotein MLL Forms a SET1-Like Histone Methyltransferase Complex with Menin To Regulate Hox Gene Expression

    Akihiko Yokoyama;Zhong Wang;Joanna Wysocka;Mrinmoy Sanyal

  • Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins.

    Paul M Ayton;Michael L Cleary

  • The Menin Tumor Suppressor Protein Is an Essential Oncogenic Cofactor for MLL-Associated Leukemogenesis

    Akihiko Yokoyama;Tim C.P. Somervaille;Kevin S. Smith;Orit Rozenblatt-Rosen

  • Immunoglobulin gene rearrangement as a diagnostic criterion of B-cell lymphoma

    Michael L. Cleary;James Chao;Roger Warnke;Jeffrey Sklar

  • Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9

    Paul M. Ayton;Michael L. Cleary

  • Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization

    D. C. Tkachuk;C. A. Westbrook;Michael Andreeff;T. A. Donlon

  • A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors.

    Inigo Espinosa;Cheng Han Lee;Mi Kyung Kim;Bich Tien Rouse

  • Menin Critically Links MLL Proteins with LEDGF on Cancer-Associated Target Genes

    Akihiko Yokoyama;Michael L. Cleary

  • Pbx proteins display hexapeptide-dependent cooperative DNA binding with a subset of Hox proteins.

    C P Chang;W F Shen;S Rozenfeld;H J Lawrence

  • Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL.

    Catherine Lavau;Stephen J. Szilvassy;Robert Slany;Michael L. Cleary

  • The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation.

    Z Chen-Levy;J Nourse;M L Cleary

Frequent Co-Authors

Roger A. Warnke
Roger A. Warnke Stanford University
Jeffrey Sklar
Jeffrey Sklar Yale University
Licia Selleri
Licia Selleri University of California, San Francisco
Stephen P. Hunger
Stephen P. Hunger University of Pennsylvania
Michael P. Link
Michael P. Link Stanford University
Ronald Levy
Ronald Levy Stanford University
Irving L. Weissman
Irving L. Weissman Stanford University
Matthew H. Porteus
Matthew H. Porteus Stanford University
Michael C. Bassik
Michael C. Bassik Stanford University
Timothy A. Donlon
Timothy A. Donlon University of Hawaii at Manoa

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Molecular Biology in the USA opens doors to a range of related online degrees and career opportunities. Students interested in the intersection of biology, behavior, and health often look toward interdisciplinary programs. Many choose to pursue advanced studies in fields like forensic psychology, which offers several high paying jobs in forensic psychology for those with a biology or life sciences background.

If you are passionate about mental health and development, internet-based programs offer flexibility and affordability. Consider pursuing child psychology masters programs online to expand your expertise or focus on a counseling career by enrolling in online master's in counseling, which builds vital skills for guiding others through personal and emotional challenges.

For those aiming for clinical roles, accredited online clinical psychology programs can complement your scientific foundation and broaden your impact in healthcare or research settings. Each of these pathways benefits from a solid grounding in molecular biology, preparing graduates for diverse, rewarding roles in both science and patient-centered fields.

Best Scientists Citing Michael L. Cleary

Trending Scientists

Recently Published Articles